Primary Author
|
Session |
Abstract Title
|
Alejandro Gutierrez
|
YI Award Winner
|
Pten Inactivation Promotes Loss of MYC "Oncogene Addiction" in a Conditional Zebrafish Model of T-ALL |
| Carl Allen |
YI Award Winner
|
Cell-Specific Gene Expression in LCH: Back to Histiocytosis X? |
| Winfred Wang |
300A/Plenary Session
|
Hydroxyurea Treatment of Infants with Sickle Cell Anemia: Results of the BABY HUG Study |
Kirk Schultz
|
300B/Plenary Session
|
Continuous Dosing Imatinib with Intensive Chemotherapy gives Equivalent Outcomes To Allogeneic BMT with Longer Term Follow Up |
Mignon Loh
|
301A/Platform Session
|
Patients with Early T-Cell Precursor (ETP) Acute Lymphoblastic Leukemia have high levels of minimal residual disease at the end of induction--A Children's Oncology Group (COG) study |
Jennifer Walker
|
301B/Platform Session
|
The Role of Deregulated Endocytosis in the Pathogenesis of CALM-AF10 Leukemias |
David Barrett
|
301C/Platform Session and YI Travel Stipend Award Winner
|
T cells Modified with anti CD19 Chimeric Immunoreceptors Rapidly Clear Established Leukemia in a Xenograft Model
|
| Wafik Zaky |
301D/Platform Session and YI Travel Stipend Award Winner
|
IKAROS Deletion Leads to Chemotherapy Resistance in Pediatric Acute Lymphoblastic Leukemia |
Michael Callaghan
|
302A/Platform Session
|
Bortezomib Induces Immune Tolerance in Hemophilia A Through Activation of the Unfolded Protein Response in B-lymphocytes
|
Tracie Goldberg
|
302B/Platform Session
|
Primitive Erythropoiesis Defect in Rpl5- Deficient Murine Embryonic Stem (ES) Cell Model of Diamond-Blackfan Anemia |
Timothy McCavit
|
302C/Platform Session
|
The Effectiveness of the Pneumococcal Conjugate Vaccine in Children with Sickle Cell Disease: A National Study of Hospitalization for Invasive Pneumococcal Disease
|
| Jane Hankins |
302D/Platform Session
|
From Infancy to Adolescence: Over a Decade of Continuous Hydroxyurea Therapy In Sickle Cell Anemia |
Kristen Eisenman
|
303A/Platform Session and YI Travel Stipend Award Winner
|
Mer Receptor Tyrosine Kinase as a Potential Novel Target in Acute Myeloid Leukemia |
Laura Hogan
|
303B/Platform Session
|
Gene Expression Analysis Reveals Distinct Signatures for Early and Late Relapse in Pediatric Acute Lymphoblastic Leukemia (ALL)
|
Patrick Zweidler-McKay
|
303C/Platform Session
|
Refining MRD-Based Risk Stratification in Pediatric ALL using Absolute Lymphocyte Counts |
Sarah Vaiselbuh
|
303D/Platform Session
|
Ectopic Human Mesenchymal Stem Cell-Coated Scaffolds Create an In Vivo Leukemia Niche in NOD/SCID Mice
|
Eduard Panosyan
|
304A/Platform Session and YI Travel Stipend Award Winner
|
Clinical Outcome in Pediatric Glial and Embryonal Brain Tumors Correlates with In Vitro Multi-passageable Neurosphere Formation |
Kelsey Johnson
|
304B/Platform Session
|
Safety and Efficacy of Tandem (131)I-Metaiodobenzylguanidine Infusions in Relapsed/Refractory Neuroblastoma
|
David Delgado
|
304C/Platform Session
|
The Potential Role for Genotypes of Killer Immunoglobulin-Like Receptors, Their Ligands, and Fc Receptors to IgG on Antitumor Responses of Neuroblastoma Patients Receiving the Hu14.18-IL2 (EMD 273063) Immunocytokine: A Children's Oncology Group Report |
Lisa Crose
|
304D/Platform Session
|
FGFR4 as a Therapeutic Target in Human Alveolar versus Embryonal Rhabdomyosarcoma |
